Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pathology and Oncology Research

• Publication date

  2011-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12253-011-9376-9PMID 21487776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrating molecular diagnostics into anticancer drug discovery

  2010cited by this paper
• Human papillomavirus and survival of patients with oropharyngeal cancer.

  2010cited by this paper
• p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer.

  2010cited by this paper
• Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.

  2009cited by this paper
• The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

  2009cited by this paper
• Human papillomavirus in HNSCC: recognition of a distinct disease type.

  2008cited by this paper
• Collagen XVII/BP180 Protein Expression in Squamous Cell Carcinoma of the Skin Detected With Novel Monoclonal Antibodies in Archived Tissues Using Tissue Microarrays and Digital Microscopy

  2008influential reference
• Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer.

  2008cited by this paper
• Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma

  2008cited by this paper
• Epidermal growth factor receptor biology in head and neck cancer.

  2006cited by this paper
• Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.

  2005cited by this paper
• Prognostic Significance of p16 Protein Levels in Oropharyngeal Squamous Cell Cancer

  2004cited by this paper
• Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior

  2004cited by this paper
• The p16 (CDKN2a/INK4a) Tumor-Suppressor Gene in Head and Neck Squamous Cell Carcinoma: A Promoter Methylation and Protein Expression Study in 100 Cases

  2003cited by this paper
• P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines

  2003cited by this paper
• Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

  2002cited by this paper
• Progression Difference between Cancers of the Larynx and Hypopharynx is Not Due to Tumor Size and Vascularization

  2001cited by this paper
• p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

  2000cited by this paper
• Ki‐67 (MIB1), p53, and Lewis‐X (LeuM1) as Prognostic Factors of Recurrence in T1 and T2 Laryngeal Carcinoma

  2000cited by this paper
• p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck.

  2000cited by this paper
• Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx.

  2000cited by this paper
• Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

  1998cited by this paper
• Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

  1998cited by this paper
• Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.

  1998cited by this paper
• Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

  1995cited by this paper
• Frequent p53 mutations in head and neck cancer.

  1992cited by this paper
• The barrier-like role of activated connective tissue against the spread of supraglottic laryngeal carcinoma

  1988cited by this paper

• The effect of the COVID-19 pandemic on TNM status among head and neck cancer patients in Hungary.

  2026cites this paper
• Spectral analysis in metabolomics of skin neoplasms

  2025cites this paper
• G protein-coupled estrogen receptor 1 and collagen XVII endodomain expression in human cutaneous melanomas: can they serve as prognostic factors?

  2024cites this paper
• The role and clinical significance of microRNA-29a-3p in the development of hypopharyngeal carcinoma

  2023cites this paper
• Metabolomics of head and neck cancer in biofluids: an integrative systematic review

  2023cites this paper
• Characterisation of waterlogged archaeological wood from Nanhai No. 1 shipwreck by multidisciplinary diagnostic methods

  2022cites this paper
• Expression Profile of Survivin and p16 in Laryngeal Squamous Cell Carcinoma: Contribution of Tunisian Patients

  2021cites this paper
• BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• A Study of Prognostic Factors in Young Patients With Non-HPV Oral Cancer in Central Europe

  2021cites this paper
• Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival

  2020cites this paper
• University of Groningen Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas Wachters,

  2020cites this paper
• The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond

  2020cites this paper
• Distinct Biomarker Profiles and Clinical Characteristics in T1‐T2 Glottic and Supraglottic Carcinomas

  2020cites this paper
• Associations between FDG-PET and Ki 67-index in head and neck cancer

  2019cites this paper
• Elevated expression of keratin 17 in oropharyngeal squamous cell carcinoma is associated with decreased survival

  2018cites this paper
• Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer

  2017cites this paper
• Investigation of urinary volatomic alterations in head and neck cancer: a non-invasive approach towards diagnosis and prognosis

  2017cites this paper
• Comparison of Histological and Proliferation Features of Canine Oral Squamous Cell Carcinoma Based on Intraoral Location: 36 Cases

  2017cites this paper
• The Prognostic Value of P16 Expression in Laryngeal Squamous Cell Carcinomas: A Large Cohort Study of Chinese Patients

  2017cites this paper
• THE IMPORTANCE OF STUDYING THE PROLIFERATION MARKER KI-67 IN PRECANCEROUS CONDITIONS AND EARLY LARYNGEAL CANCER

  2017cites this paper
• In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion

  2016cites this paper
• Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.

  2016cites this paper
• Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma

  2016cites this paper
• Collagen XVII Shedding Suppresses Re-Epithelialization by Directing Keratinocyte Migration and Dampening mTOR Signaling.

  2016cites this paper
• Correlations Between Prognosis and Regional Biomarker Profiles in Head and Neck Squamous Cell Carcinomas

  2015cites this paper
• The Role of Protein p16INK4a in Glottic Laryngeal Squamous Cell Carcinoma

  2014cites this paper
• IRM de perfusion des tumeurs de l'oropharynx : différenciation p16+/p16- en imagerie fonctionnelle

  2014cites this paper
• Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma.

  2013cites this paper
• Expression of excision repair cross-complementation group 1(ERCC1), ribonucleotide reductase M1 (RRM1) and class III beta-tubulin in head and neck carcinoma and its clinical significance

  2013cites this paper
• Capturing and Deciphering the Molecular Signatures of Head and Neck Cancer

  2013cites this paper
• Serum and tissue metabolomics of head and neck cancer.

  2013cites this paper
• Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.

  2012cites this paper